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ϩ current (IKs) is important for repolarization of ventricular AP. We examined the effects of IKs activation by a new benzodiazepine (L3) on the AP of control, dofetilide-treated, and hypertrophied rabbit ventricular myocytes. In both control and hypertrophied myocytes, L3 activated IKs via a negative shift in the voltage dependence of activation and a slowing of deactivation. L3 had no effect on L-type Ca 2ϩ current or other cardiac K ϩ currents tested. L3 shortened AP of control, dofetilide-treated, and hypertrophied myocytes more at 0.5 than 2 Hz. Selective activation of IKs by L3 attenuates prolonged AP and eliminated EAD induced by rapidly activating delayed rectifier K ϩ current inhibition in control myocytes at 0.5 Hz and spontaneous EAD in hypertrophied myocytes at 0.2 Hz. Pharmacological activation of IKs is a promising new strategy to suppress arrhythmias resulting from excessive AP prolongation in patients with certain forms of long QT syndrome or cardiac hypertrophy and failure. action potential; ion channel; early afterdepolarization; arrhythmia CARDIAC HYPERTROPHY AND FAILURE cause Ͼ200,000 deaths annually in the United States. As many as 50% are sudden and due to the onset of polymorphic ventricular tachycardia (VT) or torsades de pointes associated with long QT syndrome (LQTS) (7) . LQTS can be congenital or acquired. Congenital LQTS most commonly develops from mutations in genes encoding delayed rectifier K ϩ channels that cause functional decreases in repolarizing K ϩ currents (4, 12, 27) . Acquired LQTS is associated with administration of certain antiarrhythmics, antihistamines, antibiotics, and other drugs (http://georgetowncert.org/qtdrugs_torsades.asp). Many of these agents can cause excessive action potential (AP) prolongation via inhibition of the rapidly activating delayed rectifier K ϩ current (I Kr ), resulting in a specific form of acquired LQTS (LQT2) (20) . Heart failure may also be considered a commonly acquired form of LQTS (16) . Functional downregulation of K ϩ currents is a recurring theme in hypertrophied and failing ventricular myocardium (26) .
At the cellular level, excessive AP prolongation and unstable repolarization is consistently observed in ventricular myocytes from hypertrophied and failing hearts, animal models or patients with LQTS (2, 7, 31) . Early afterdepolarizations (EAD) occur in the setting of prolonged AP due commonly to diminished K ϩ currents or in some cases to slowly or noninactivating components of Ca 2ϩ or Na ϩ currents. EAD have been identified as the triggering mechanisms for polymorphic VT (2, 4, 35) . Ventricular myocytes from hypertrophied and failing hearts are highly susceptible to EAD (3, 16, 17, 31) . No effective or safe drugs are available for treatment of acquired LQT2 or ventricular arrhythmias associated with cardiac hypertrophy and failure.
We hypothesized that selective activation of the slowly activating delayed rectifier K ϩ current (I Ks ) could provide an effective antiarrhythmic action in certain forms of LQTS and heart failure. Recently, we (22) identified a new benzodiazepine (L3), a selective activator of I Ks , which shortened AP of guinea pig ventricular myocytes. In this study of rabbits, we investigated whether L3-induced activation of I Ks could abbreviate AP and suppress EAD resulting from I Kr inhibition in acquired LQT2 or diminished I Ks in left ventricular (LV) hypertrophy (LVH).
METHODS
Experimental animals. Male New Zealand White rabbits (1.4-2.0 kg) underwent unilateral nephrectomy and contralateral renovascular banding to produce LVH, as reported previously (19) . Banded rabbits were studied 3 mo after surgery when documented LVH had developed. Data were collected from 15 control and 9 LVH rabbits.
Myocyte isolation. Single ventricular myocytes were isolated using a method described previously (19) . After enzyme perfusion, a thin layer (Ͻ1.5 mm) of tissue was dissected from the epicardial (Epi) and endocardial (Endo) surface of the LV free wall (excluding the extreme apex and base) and myocytes were dispersed.
AP recording. APs were recorded from Epi and Endo myocytes using standard microelectrodes (25-40 M⍀) filled with 3 M KCl. Cells were superfused with a solution containing (in mM) 137 NaCl, 5 KCl, 1 MgCl 2, 2 CaCl2, 10 glucose, and 10 HEPES, pH 7.4, at 36 Ϯ 0.3°C. AP were recorded at steady state using various stimulus frequencies (0.2, 0.5 and 2 Hz). AP duration (APD) was measured at 90% repolarization (APD 90). Because of the beat-to-beat variation of APD, especially at low frequencies, APD90 was averaged from 10 consecutive APs.
Membrane current recording. Membrane ionic currents were recorded at 36 Ϯ 0.5°C using the whole cell patch-clamp technique. The following five solutions were used, composed of (in mM): 1) I Ks Epi myocytes were chosen for I Ks recording due to their relatively larger IKs density than in Endo myocytes (32) . IKs was recorded with 1-s depolarizing voltage steps applied at 12-s interpulse intervals from a holding potential (V h) of Ϫ40 mV to test potentials (Vt) of Ϫ20 to ϩ60 mV in 20-mV increments (32) . Isochronal activation curves for IKs were determined from peak tail current amplitudes during return to a V h of Ϫ40 mV after 5-s test pulses. Tail currents (I) were normalized to the maximal tail current (Imax) obtained after a step to Vt of ϩ70 mV. A Boltzmann function,
where V0.5 is the half-maximal activation potential and k is the slope factor, was fit to the data. Current-voltage (I-V) relations were plotted for averaged data normalized to cell capacitance. A second-order exponential function was fit to the deactivating tail current on return to Ϫ40 mV after a 5-s test pulse to ϩ30 mV to derive the time constants of I Ks deactivation.
IKr was induced by 500-ms pulses to Vt of Ϫ10 mV from a Vh of Ϫ50 mV. Six consecutive pulses were delivered at 0.2 Hz and the current traces were averaged. IKr was quantified as dofetilide-sensitive tail current. ICa,L was recorded with 180-ms test pulses applied at a 5-s interpulse interval from a V h of Ϫ40 mV to Vt of Ϫ30 to ϩ50 mV in 10-mV increments.
Data analysis. Data are expressed as means Ϯ SE. Statistical analyses were performed with the use of Prism version 2.0 software (GraphPad). A paired t-test was used to compare control and L3 treatment means. A two-way analysis of variance was used to compare means involving two different categorical variables. P Ͻ 0.05 was considered statistically significant.
Drugs. L3 was synthesized at Merck Research Laboratories (West Point, PA), as previously described (22) . Dofetilide and nisoldipine were gifts from Pfizer and Bayer, respectively.
RESULTS
The effects of L3 on I Ks in ventricular myocytes of control rabbits are shown in Fig. 1 . L3 throughout these studies was tested at its maximally effective concentration of 1 M unless otherwise noted (22) . Compared with control (Fig. 1A) , L3 increased I Ks amplitude and slowed deactivation (Fig. 1B) . L3 increased I Ks significantly at all V t (Fig. 1D) . At a V t of ϩ60 mV, L3 increased I Ks density from 2.31 Ϯ 0.35 to 3.05 Ϯ 0.46 pA/pF (n ϭ 10). Percent increases in I Ks declined with increasing membrane potential, 286 Ϯ 20% at Ϫ20 mV versus 32 Ϯ 2% at ϩ60 mV (n ϭ 10, Fig. 1E ). L3 shifted the midpoint (V 0.5 ) of the voltage dependence of I Ks activation by Ϫ17.6 mV (Fig. 1F) . In control, deactivation of I Ks was best described by a second-order exponential function. L3 increased the fast ( f ) and slow ( s ) time constants of I Ks deactivation from 95 Ϯ 7 to 116 Ϯ 14 ms (n ϭ 6, not significant) and from 279 Ϯ 25 to 712 Ϯ 127 ms (n ϭ 6, P Ͻ 0.05), respectively. Figure 1C shows the ratio of I Ks in the presence of L3 to the control for a test pulse to ϩ60 mV. During the test pulse, L3 increased activating I Ks by a constant ratio of ϳ1.4 for the entire duration of the pulse, analogous to the increase in current density measured at the end of the pulse. On repolarization to Ϫ40 mV, the initial deactivating tail current is increased to a degree similar to that during the pulse. More importantly, however, because L3 slowed I Ks deactivation, the relative increase in I Ks was greater at later times in the deactivation process, such that at 1 s after repolarization, the relative current was increased by ϳ10-fold.
L3 had no effect on I Ca,L at all V t . There was also no evidence for use-dependent block of I Ca,L during repetitive 500-ms pulses from a V h of Ϫ40 mV to a V t of ϩ20 mV at 0.5 Hz (data not shown). L3 reduced I Kr tail current slightly but not significantly from 86 Ϯ 9 to 82 Ϯ 10 pA (n ϭ 6), and had no significant effect on inward rectifier K ϩ current or transient outward K ϩ current (data not shown). Thus, by all of these measures, L3 was a selective activator of I Ks . L3 concentration dependently shortened AP in rabbit control ventricular myocytes (Fig. 2) . L3 (1 M) decreased APD 90 at 0.5 and 2 Hz by 23 Ϯ 2% and 17 Ϯ 2% in Epi and by 21 Ϯ 2% and 14 Ϯ 2% in Endo, respectively (n ϭ 8). Percent decreases in APD 90 were similar between Epi and Endo myocytes, but were more pronounced at 0.5 than at 2 Hz.
L3 attenuated AP prolongation and eliminated EAD induced by the specific I Kr blocker dofetilide in myocytes isolated from control rabbits (Fig. 3) . At a stimulus frequency of 0.5 Hz, 0.1 M dofetilide induced EAD in 4 of 11 Endo myocytes. L3 eliminated EAD in all four cells in the continuous presence of 0.1 M dofetilide (Fig. 3A) . The effects of L3 were reversible; e.g., EAD reappeared during washout of L3 (data not shown). In the presence of 0.1 M dofetilide, L3 decreased APD 90 from 315 Ϯ 41 to 245 Ϯ 32 ms in Epi myocytes and 627 Ϯ 135 to 388 Ϯ 70 ms in Endo myocytes at 0.5 Hz (n ϭ 8). L3 effects on APD were frequency dependent. L3 decreased APD 90 by 15 Ϯ 1% and 13 Ϯ 1% at 2 Hz and by 24 Ϯ 2% and 35 Ϯ 3% at 0.5 Hz in Epi and Endo, respectively (n ϭ 8). AP prolonged by 0.1 M dofetilide in myocytes from both Epi and Endo were shortened to a lesser extent at 2 Hz than 0.5 Hz by L3. In the presence of dofetilide, L3 decreased APD 90 more in Endo (239 Ϯ 69 ms) than Epi myocytes (70 Ϯ 11 ms) at 0.5 Hz (n ϭ 8, P Ͻ 0.05).
Three months after renal artery banding, rabbits developed LVH with characteristic changes. LVH significantly increased the heart weight-to-body weight ratio from 2.10 Ϯ 0.04 (n ϭ 15) to 2.53 Ϯ 0.07 g/kg (n ϭ 9, P Ͻ 0.05) and myocyte size, measured as cell membrane capacitance, from 158 Ϯ 7 (n ϭ 20) to 200 Ϯ 12 pF (n ϭ 16, P Ͻ 0.05). Consistent with our previous findings (32) , I Ks density of rabbit LVH myocytes was significantly lower than that of controls, 1.15 Ϯ 0.21 versus 2.31 Ϯ 0.35 pA/pF (n ϭ 10, P Ͻ 0.05). L3 had similar effects on I Ks of myocytes from both control and LVH rabbits (Figs. 1D and 4A) . At a V t of ϩ60 mV, L3 increased I Ks density from 2.31 Ϯ 0.35 to 3.05 Ϯ 0.46 pA/pF and from 1.15 Ϯ 0.21 to 1.51 Ϯ 0.26 pA/pF, respectively (n ϭ 10). L3 increased I Ks by 264 Ϯ 9% at Ϫ20 mV and 34 Ϯ 4% at ϩ60 mV in myocytes from LVH rabbits (n ϭ 10, Fig. 4B ). L3 shifted the midpoint (V 0.5 ) of the voltage dependence of I Ks activation in LVH rabbits by Ϫ19.0 mV (Fig. 4C) .
As observed previously (32) , APD 90 of Epi and Endo ventricular myocytes in LVH rabbits was increased by 21% and 22% at 2 Hz, respectively, compared with controls. At 0.5 Hz, APD 90 increased from 175 Ϯ 15 to 212 Ϯ 27 ms by LVH in Epi and from 231 Ϯ 18 to 296 Ϯ 35 ms in Endo myocytes, respectively (n Ն 11). Spontaneous EAD were recorded in 3 of 13 myocytes from Endo of LVH rabbits at a stimulus frequency of 0.2 Hz. L3 eliminated EAD in all three cells (Fig. 5A) . In LVH myocytes, 1 M L3 decreased APD 90 by 19 Ϯ 2% and 13 Ϯ 1% in Epi and by 17 Ϯ 2% and 13 Ϯ 1% in Endo at 0.5 and 2 Hz, respectively (n ϭ 8). Percent decreases of APD 90 by L3 were similar between Epi and Endo at both 0.5 and 2 Hz. However, L3 decreased APD 90 more at 0.5 Hz than at 2 Hz.
DISCUSSION
This study provides the first direct evidence that I Ks activation can be useful in reversing excessive AP prolongation and suppressing arrhythmogenic EAD in certain forms of LQTS. We examined this utility in rabbit models of acquired LQTS using the selective activator of I Ks , L3, described previously in detail (22) . In a model of LQT2, I Kr inhibition with dofetilide produced typical reverse frequency-dependent increases in APD and EAD (25) . In a model of LVH induced by renovascular hypertension, APD were prolonged, spontaneous EAD occurred in 23% of Endo myocytes at 0.2 Hz, and I Ks density was significantly reduced, consistent with our previous findings (32) . These profiles of abnormal repolarization reflect deficiencies in two major repolarizing currents, I Kr and I Ks , respectively.
More importantly, in control, dofetilide-treated, and LVH myocytes, L3 shortened APD in a concentrationdependent manner and eliminated EAD in the latter two conditions. AP mapping across the LV free wall using arterially perfused wedge preparations shows that Endo has the longest and Epi the shortest APD in both control and LVH rabbits (33) . Across the LV free wall, there is a gradual increase in APD from the Epi side to the Endo side. This differs from the canine left ventricle where the longest APD is recorded in subendocardium (M cells) (34) . L3 decreased APD to a similar degree in Epi and Endo myocytes in both control and LVH (Fig. 2B and 5C ), indicating that I Ks activation by L3 in rabbits should not increase transmural dispersion of repolarization. In dofetilide-treated myocytes, L3 decreased APD more significantly in Endo than Epi at 0.5 Hz, due partly to elimination of EAD in Endo. Thus, in acquired LQT2 or abnormally prolonged repolarization due to I Kr inhibition, I Ks activation should actually decrease transmural dispersion of repolarization.
L3 decreased APD more at 0.5 Hz than 2 Hz in control, dofetilide-treated, and LVH myocytes. Because excessive AP prolongation, EAD, and torsades de pointes are associated with bradycardia, this characteristic of L3 could be particularly beneficial. Because of the complicated interaction of many time and voltage-dependent currents in controlling AP morphology, it is oversimplified to extrapolate changes in a single current to effects on APD. Nevertheless, the L3-induced slowing of deactivation may provide a basis for the greater shortening of APD observed at slower rates. Normally, due to its slow deactivation, I Ks can accumulate more at higher frequencies and thereby contribute to the rate-dependent shortening of APD (11, 13, 24) . L3 slows I Ks deactivation and increases relative deactivating current more at later times or longer intervals (Fig. 1C) . The larger relative increases in deactivating I Ks at longer intervals may lead to greater than normal accumulation at the slower rates and explain the greater decreases in APD by L3 at 0.5 Hz than at 2 Hz. However, the mechanism underlying the frequency-dependent effects of L3 on APD still requires further study.
L3 concentration dependently activated I Ks and shortened APD in guinea pig ventricular myocytes (22) . In this study, L3 effects on rabbit I Ks were studied at a maximally effective concentration of 1 M as determined previously for the guinea pig. L3 increased I Ks in rabbit via a negative shift in the voltage-dependence of activation and a slowing of deactivation. L3 shifted the V 0.5 of rabbit I Ks activation by Ϫ17.6 mV in control and by Ϫ19.0 mV in LVH, comparable to the shift of Ϫ24 mV found previously for the guinea pig. This shift accounts for the larger percent increases of I Ks at more negative V t (Figs. 1E and 4B) . Deactivation of I Ks was best described by a second-order exponential function. L3 increased both f (22%) and s (155%) of deactivation of rabbit I Ks , consistent with the changes in the guinea pig (70% and 190%, respectively).
Our experimental results indicate that L3 (up to 1 M) is a selective activator of I Ks in rabbit ventricular myocytes. L3 also slows deactivation of I Ks . These selective actions on the gating of I Ks are likely the predominant (if not only) mechanisms underlying the APD shortening and EAD elimination by L3. Both the negative shift in the voltage dependence of activation and the slowing of deactivation can increase the contribution of I Ks to AP repolarization.
A reduction of repolarizing K ϩ currents in LQTS and hypertrophied hearts has been widely observed. Reductions in the density of the transient outward K ϩ current and the inward rectifier K ϩ current are commonly observed in cardiac hypertrophy and failure (26) . Reductions in I Ks and I Kr , which play dominant roles in ventricular AP repolarization of many mammalian species including the rabbit (21), are also common. In cats, I Ks density was decreased in right ventricular hypertrophy induced by pressure overload (14) and LVH was induced by aortic stenosis (10) . In rabbits, LVH induced by renovascular hypertension significantly reduced I Ks but not I Kr density (32) , whereas pacing-induced heart failure reduced both I Ks and I Kr (28) . In dogs with chronic complete atrioventricular block, I Kr density of midmyocardial cells was decreased in right ventricle and I Ks density was decreased in both ventricles (30) . In failing human hearts, I Ks density was decreased by 60% (15) . The reduction in the delayed rectifier K ϩ currents predisposes ventricular myocytes to potentially arrhythmogenic EAD (9, 17, 32) . Computer models of the mammalian ventricular AP predict that reducing I Ks induces EAD in the endocardial cells during normal cell-cell coupling (29) .
Other studies aimed at treating arrhythmias resulting from excessive AP prolongation and LQTS have explored various strategies for augmenting repolarizing K ϩ currents. These include increasing I Kr by elevating serum K ϩ concentrations (5, 6), administration of ATP-sensitive K ϩ channel openers (1, 8, 23) , and overexpression of the human ether-á -go-go-related gene (18) .
Study limitations. Because excessive APD prolongation and EAD are associated with bradycardia, the pacing rates used in this study are below the normal physiological rates in the rabbit. The rabbit models used in this study address only the downregulation of I Kr amplitude (acquired LQT2) or I Ks density (LVH). In patients with congenital LQTS, not only is current density affected, but also other properties of I Kr or I Ks channels may change. It is uncertain whether I Ks activation will have antiarrhythmic effects in these patients. Use of I Ks activators may not be void of adverse effects in some situations. Shortening APD by I Ks activation may facilitate the development of reentrant arrhythmia under certain circumstances, particularly in myocardial ischemia and infarction. The effects of L3 on action potentials under ischemic conditions are unknown; however, we expect the APD shortening by I Ks activation would be very modest and possibly overwhelmed by activation of the large conductance of the ATP-sensitive K ϩ channel current. In conclusion, selective activation of I Ks by pharmacological agents is a promising new strategy to suppress arrhythmias resulting from excessive AP prolongation in patients with certain forms of LQTS or cardiac hypertrophy and failure.
